Skip to content
Search

Latest Stories

HayMax balm recognised as 'Best British Allergy Product 2022'

HayMax, maker of the famous organic drug-free allergen barrier balm has been awarded the ‘British Made Award’ for Best British Allergy Product 2022.

The award celebrates businesses that work tirelessly to make their region one of the most diverse and dynamic the UK has to offer.


HayMax MD and creator Max Wiseberg comments: “This award means a great deal to us. We’ve always been proud that our products have been manufactured in the UK. We are passionate about reducing the cost to the environment so being British-made means we keep the miles down and reduce our carbon footprint.”

HayMax balms are manufactured in the UK. It buys local to reduce the cost to the environment, even if it means it costs a bit more. HayMax’s current pots are now made in the UK, which has been great for reducing their carbon footprint. Its tins come from London.

The new pots can be recycled and re-used. The brand has now switched to using sugar cane to make its pots and has also reduced the amount of material used in the pots by just over 54%. And they have switched from the plastic labels to paper labels.

These pots are recyclable with the roadside collection. So now, HayMax is making a positive contribution to climate change, using up CO2 instead of producing it.

HayMax allergen barrier balms are different from most hay fever products, which work by trying to deal with these symptoms. Instead, HayMax seeks to stop the cause of the problem – namely too much pollen in the body – from occurring.

This helps prevent symptoms completely or helps reduce the severity of symptoms by reducing the pollen load. Prevention rather than cure – since there is currently no cure for hay fever.

Independent university studies have shown that HayMax traps significantly more pollen than an uncoated nostril, and traps all types of grass and tree pollen and that HayMax traps over a third of pollen before it enters the body, in addition to dust mite allergens and pet dander. In an independent survey by Allergy UK, the leading national charity providing support, advice and information for those living with allergic disease, 80% of people say HayMax works. And 94% of people find HayMax quick to be effective; 44% said that it worked immediately and a further 35% said that it worked within an hour or two.

HayMax balms are organic, drug-free and non-drowsy which means they’re suitable for children as well as pregnant and breast-feeding mums. They can also be used whilst driving, operating machinery, for exams and sports.

HayMax organic drug-free allergen barrier balms have an rrp of £8.49 per pot and are available from wholesalers to the health store and pharmacy trade, including Hunts Foods, Queenswood, Jumla, CLF, Avvrax, Hampdens, Sundrelle and Sigma, direct on 01525 406600 or www.haymax.biz.

The HayMax range is supported by national PR and advertising campaigns and POS materials, including giant display boxes, CDUs, leaflets, posters and shelf barkers.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less